Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials!!

Clinical Trial 6989

Omaha, NE 68114

Study Summary:

A multicenter, randomized, double-blind, placebo-controlled study to determine the efficacy and safety of Alogliptin plus Metformin, Alogliptin alone, or Metformin alone in subjects with Type II Diabetes.

Qualified Participants Must:

• Be 19 years of age or older
• Have Type II Diabetes
• Currently not taking any diabetic medication

Qualified Participants May Receive:

Study medication, physical exams, and lab work at no cost.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.